SNG V vaccine23 Jul 2020 16:22
Professor Stephen Holgate, one of Synairgen’s co-founders, described it as having “huge potential” for restoring the natural immune system response in a patient’s lungs.
He added that not only does SNG001 help the lungs combat Covid-19, but it could become a more important treatment than any future vaccines which may have to be re-engineered as the virus mutates in the future.